Justin Bowers
Stock Analyst at Deutsche Bank
(1.74)
# 3,168
Out of 4,876 analysts
49
Total ratings
35.48%
Success rate
1.38%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $310 → $325 | $354.91 | -8.43% | 3 | Nov 4, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $158.16 | +67.55% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $5.20 | +342.31% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $20.69 | +40.16% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $98.03 | +3.03% | 11 | Jul 31, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $395 → $336 | $306.80 | +9.52% | 2 | Jul 24, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $11.70 | +113.68% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $124.23 | +24.77% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $412.12 | +48.02% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $52.80 | +55.30% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $13.74 | +81.95% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $2.38 | +614.29% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $146.75 | +104.43% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $201.46 | +36.50% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $219.00 | +14.16% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $151.59 | +91.31% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $15.01 | +206.46% | 5 | May 10, 2021 |
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $310 → $325
Current: $354.91
Upside: -8.43%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $158.16
Upside: +67.55%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $5.20
Upside: +342.31%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $20.69
Upside: +40.16%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $98.03
Upside: +3.03%
Medpace Holdings
Jul 24, 2024
Maintains: Hold
Price Target: $395 → $336
Current: $306.80
Upside: +9.52%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $11.70
Upside: +113.68%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $124.23
Upside: +24.77%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $412.12
Upside: +48.02%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $52.80
Upside: +55.30%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $13.74
Upside: +81.95%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $2.38
Upside: +614.29%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $146.75
Upside: +104.43%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $201.46
Upside: +36.50%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $219.00
Upside: +14.16%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $151.59
Upside: +91.31%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $15.01
Upside: +206.46%